Cargando…

Systematic Construction and Validation of a Prognostic Model for Hepatocellular Carcinoma Based on Immune-Related Genes

Hepatocellular carcinoma (HCC), a highly aggressive tumor, has high incidence and mortality rates. Recently, immunotherapies have been shown to be a promising treatment in HCC. The results of either the CheckMate-040 or IMbrave 150 trials demonstrate the importance of immunotherapy in the systemic t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Jiahao, Ma, Shuoyi, Tian, Siyuan, Zhang, Miao, Ding, Xiaopeng, Liu, Yansheng, Yang, Fangfang, Hu, Yinan, Xuan, Guoyun, Zhou, Xinmin, Wang, Jingbo, Han, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520962/ https://www.ncbi.nlm.nih.gov/pubmed/34671598 http://dx.doi.org/10.3389/fcell.2021.700553

Ejemplares similares

Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
por: Hu, Yinan, et al.
Publicado: (2022)

Immunoglobulin M: A Neglected Serum Biomarker in Treatment‐Naive Primary Biliary Cholangitis With Normal Alkaline Phosphatase
por: Ding, Dawei, et al.
Publicado: (2022)

Construction and Validation of Two Hepatocellular Carcinoma-Progression Prognostic Scores Based on Gene Set Variation Analysis
por: He, Qifan, et al.
Publicado: (2022)

Systematic Construction and Validation of an RNA-Binding Protein-Associated Model for Prognosis Prediction in Hepatocellular Carcinoma
por: Tian, Siyuan, et al.
Publicado: (2021)

MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Colorectal Cancer
por: Yang, Fangfang, et al.
Publicado: (2022)

Construction and Validation of a Cell Cycle-Related Robust Prognostic Signature in Colon Cancer
por: Zhang, Zhiyuan, et al.
Publicado: (2020)

Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

Development and validation of a copper-related gene prognostic signature in hepatocellular carcinoma
por: Shi, Haoting, et al.
Publicado: (2023)

Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic Cancer
por: Chen, Guangyu, et al.
Publicado: (2022)

Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6/STAT3 pathway in macrophages
por: Tian, Siyuan, et al.
Publicado: (2022)

Construction and Validation of a Ferroptosis-Related Prognostic Signature for Melanoma Based on Single-Cell RNA Sequencing
por: Liu, Yating, et al.
Publicado: (2022)

Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma
por: Zhang, Ze, et al.
Publicado: (2022)

Development and Validation of a Novel Mitochondrion and Ferroptosis-Related Long Non-Coding RNA Prognostic Signature in Hepatocellular Carcinoma
por: Xia, Wuzheng, et al.
Publicado: (2022)

Construction of a novel exosomes-related gene signature in hepatocellular carcinoma
por: Tao, Qiqi, et al.
Publicado: (2022)

Establishment and Validation of Prognostic Nomograms Based on Serum Copper Level for Patients With Early-Stage Triple-Negative Breast Cancer
por: Duan, Fangfang, et al.
Publicado: (2021)

Construction and Validation of a 15-Top-prognostic-gene-based Signature to Indicate the Dichotomized Clinical Outcome and Response to Targeted Therapy for Bladder Cancer Patients
por: Gu, Hongbing, et al.
Publicado: (2022)

Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment
por: Zhang, Yuanyuan, et al.
Publicado: (2021)

Identification of Hypoxia–Immune-Related Gene Signatures and Construction of a Prognostic Model in Kidney Renal Clear Cell Carcinoma
por: Bai, Shuheng, et al.
Publicado: (2022)

Construction and Validation of a Novel Immunosignature for Overall Survival in Uveal Melanoma
por: Gu, Chufeng, et al.
Publicado: (2021)

Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in hepatocellular carcinoma
por: Wang, Xiaoqiang, et al.
Publicado: (2022)

A Novel Pyroptosis-related Prognostic Model for Hepatocellular Carcinoma
por: Wu, Qianqian, et al.
Publicado: (2021)

Progress of CRISPR-Cas13 Mediated Live-Cell RNA Imaging and Detection of RNA-Protein Interactions
por: Cao, Huake, et al.
Publicado: (2022)

Constructing Dynamic Functional Networks via Weighted Regularization and Tensor Low-Rank Approximation for Early Mild Cognitive Impairment Classification
por: Jiao, Zhuqing, et al.
Publicado: (2021)

Identification of Immune-Related Genes for Establishment of Prognostic Index in Hepatocellular Carcinoma
por: Li, Yinfang, et al.
Publicado: (2021)

Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma
por: Song, Ze-Bing, et al.
Publicado: (2021)

Construction of a Five-Super-Enhancer-Associated-Genes Prognostic Model for Osteosarcoma Patients
por: Ouyang, Zhanbo, et al.
Publicado: (2020)

Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma
por: Li, Yue, et al.
Publicado: (2021)

6-Phosphogluconolactonase Promotes Hepatocellular Carcinogenesis by Activating Pentose Phosphate Pathway
por: Li, Changzheng, et al.
Publicado: (2021)

Corrigendum: Construction of a Five-Super-Enhancer-Associated-Genes Prognostic Model for Osteosarcoma Patients
por: Ouyang, Zhanbo, et al.
Publicado: (2021)

A PARP1-related prognostic signature constructing and PARP-1 inhibitors screening for glioma
por: Li, Hui, et al.
Publicado: (2022)

RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

Identification and Validation of Immune- and Stemness-Related Prognostic Signature of Melanoma
por: Zhang, Yan, et al.
Publicado: (2021)

Identification and validation of critical genes with prognostic value in gastric cancer
por: Dong, Ningxin, et al.
Publicado: (2022)

Construction and Validation of a Novel Pyroptosis-Related Gene Signature to Predict the Prognosis of Uveal Melanoma
por: Cao, Yuan, et al.
Publicado: (2021)

Histone Deacetylases Inhibit the Snail2-Mediated EMT During Metastasis of Hepatocellular Carcinoma Cells
por: Hu, Yue, et al.
Publicado: (2020)

The Construction of Bone Metastasis-Specific Prognostic Model and Co-expressed Network of Alternative Splicing in Breast Cancer
por: Huang, Runzhi, et al.
Publicado: (2020)

Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma
por: Xu, Dafeng, et al.
Publicado: (2021)

Diagnostic, Therapeutic, and Prognostic Value of the m(6)A Writer Complex in Hepatocellular Carcinoma
por: Gu, Zongting, et al.
Publicado: (2022)

Identification of the Expression Patterns and Potential Prognostic Role of 5-Methylcytosine Regulators in Hepatocellular Carcinoma
por: Liu, Yong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9tq76u9m7u38l6mmf3eut2tmaq